Brief: Inmed Announces Share Consolidation To Meet Nasdaq Listing Criteria

InMed Pharmaceuticals

23/08/2022 22:01

Aug 23 (Reuters) - InMed Pharmaceuticals Inc  INM.O :
    * INMED ANNOUNCES SHARE CONSOLIDATION TO MEET NASDAQ LISTING
CRITERIA
    * INMED PHARMACEUTICALS- COMMON SHARES WILL BEGIN TRADING ON
SPLIT-ADJUSTED BASIS ON NASDAQ CAPITAL MARKET COMMENCING AT
MARKET OPEN, SEPTEMBER 7, 2022
    * INMED - WILL BE CONSOLIDATING ALL ISSUED & OUTSTANDING
SHARE
CAPITAL ON BASIS OF 1 POST‐CONSOLIDATION SHARE FOR EACH 25
PRE‐CONSOLIDATION  SHARES

Source text for Eikon:  ID:nGNX7WN07y 
Further company coverage:  INM.O 

 ((Reuters.Briefs@thomsonreuters.com;))